Earnings call Dr. Lal PathLabs reported Q2 FY25 revenue of ₹660 crore, up 9.8% YoY, with PAT rising 18.1% to ₹131 crore. EBITDA margin expanded to 30.7%, supported by operating leverage and product ...
The balance sheet gives him room to move - Lal PathLabs is sitting on about Rs.1,400 crore of net cash and no debt, and can ...
The ​country's largest diagnostics firm by revenue took up a one-time charge worth ₹30.1 crore linked to India's new labour ...
Jan 30 (Reuters) - Dr. Lal Path Labs reported a lower third-quarter profit on Friday after taking a one-time charge linked to India’s new labour code, despite strong demand for its bundled test ...
Jan 30 (Reuters) - India's Dr Lal Path Labs (DLPA.NS), opens new tab reported a 19% jump in its third-quarter profit on Thursday, led by continued demand for its bundle test offerings, sending its ...
Discover Dr Lal Path Labs diagnostic services in New Delhi, Delhi. Get directions and view its location on an interactive map. Search our database by state, city, or pincode to find information on ...
Discover Dr Lal Path Labs diagnostic services in Gurgaon, Haryana. Get directions and view its location on an interactive map. Search our database by state, city, or pincode to find information on ...
Earnings call Dr. Lal PathLabs reported Q3 FY25 revenue of ₹597 crore, up 10.7% YoY, with EBITDA margin at 25.8% and PAT up 19.3% YoY. Growth was driven by volume gains, improved mix, and Swasthfit ...